Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01947647 · ClinicalTrials.gov registry record · NA

Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders

A NA study of Major Depressive Disorder and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
105
Enrollment target
1
Study location

NCT01947647: Completed NA study of Major Depressive Disorder and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

NCT01947647 is a NA study of Major Depressive Disorder and Post Traumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 105 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01947647, a NA study of Major Depressive Disorder and Post Traumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

Cognitive behavioral therapy (CBT) is a brief, efficient, and effective psychotherapy for individuals with depressive and anxiety disorders. However, CBT is largely underutilized within Veteran Affairs Medical Centers (VAMCs) due to the cost and burden of trainings necessary to deliver the large number of CBT protocols. Transdiagnostic CBT, in contrast, is specifically designed to address numerous distinct disorders within a single protocol. This transdiagnostic approach has the potential to dramatically improve the accessibility of CBT within VAMCs and therefore improve clinical outcomes of Veterans. The proposed research seeks to evaluate the efficacy of a transdiagnostic CBT by assessing clinical outcomes and quality of life in VAMC patients with depressive and anxiety disorders throughout the course of treatment and in comparison to an existing evidence-based psychotherapy, behavioral activation treatment.

Primary Outcome

The DASS-Depression (Lovibond and Lovibond, 1995) is a 7-item measure designed to assess dysphoric mood. Items are rated on a 4-point Likert scale, ranging from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time), and summed to compute the total scale (range 0-21). Higher scores are indicative of greater symptom severity, with scores greater than 10 typically considered of clinical significance. Support for the factor structure, convergent and discriminant validity,

Interventions

  • BEHAVIORAL Transdiagnostic Behavior Therapy
  • BEHAVIORAL Behavioral Activation Therapy

Study Locations (1)

South Carolina

  • Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2014-11-17
Est. Completion 2018-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT01947647 record still lists

NCT01947647 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (72% lower).

The record links to 8 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Transdiagnostic Behavior Therapy is the first listed.

NCT01947647 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT01947647 about?

NCT01947647 is a clinical study titled "Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders". Cognitive behavioral therapy (CBT) is a brief, efficient, and effective psychotherapy for individuals with depressive and anxiety disorders. However, CBT is largely underutilized within Veteran Affairs Medical Centers (VAMCs) due to the cost and burden of trainings necessary to deliver the large num...

What is the current status of trial NCT01947647?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2014-11-17. Estimated completion is 2018-12-31.

What conditions does trial NCT01947647 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Post Traumatic Stress Disorder, Obsessive - Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder.

What interventions are being tested in trial NCT01947647?

The interventions under investigation include: Transdiagnostic Behavior Therapy (BEHAVIORAL), Behavioral Activation Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01947647?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01947647 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01947647's enrollment target sits among peer trials

105 129th of 282 higher than 153 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01947647, the US trial registry maintained by the National Library of Medicine. NCT01947647 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.